Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 9, Pages 1824-1830
Publisher
Springer Nature
Online
2014-09-03
DOI
10.1038/bjc.2014.479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
- (2014) K Kavanagh et al. BRITISH JOURNAL OF CANCER
- Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
- (2014) B. Baldur-Felskov et al. JNCI-Journal of the National Cancer Institute
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
- (2013) Kimberley Kavanagh et al. BMC INFECTIOUS DISEASES
- Achieving high and equitable coverage of adolescent HPV vaccine in Scotland
- (2013) Katy Sinka et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes
- (2013) Tom Glass Hopkins et al. VACCINE
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
- (2012) Suzanne E. Powell et al. VACCINE
- Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England
- (2012) Harriet L. Bowyer et al. VACCINE
- Using computerised decision support to improve compliance of cancer multidisciplinary meetings with evidence-based guidance
- (2012) Vivek Patkar et al. BMJ Open
- HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland
- (2011) M C O'Leary et al. BRITISH JOURNAL OF CANCER
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- ‘A False Sense of Security’? Understanding the Role of the Hpv Vaccine on Future Cervical Screening Behaviour: A Qualitative Study of Uk Parents and Girls of Vaccination Age
- (2011) Lorna Henderson et al. JOURNAL OF MEDICAL SCREENING
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
- (2010) K Cuschieri et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now